p53 mutant His175identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6
- 10 October 1994
- journal article
- Published by Wiley in FEBS Letters
- Vol. 353 (1), 29-32
- https://doi.org/10.1016/0014-5793(94)00953-8
Abstract
Fallopian tube carcinoma is a lethal gynecologic malignancy. Etiologic factors are unknown. No experimental data on molecular alterations exist so far. For an in vitro model, we established the permanent human tubal carcinoma cell line FT-MZ-1. The median doubling time was 14 days with 24.2% in S phase. A point missense mutation of the p53 tumor suppressor gene resulting in the His175 mutant was identified. Aberrant p53 protein accumulated in nucleus and cytoplasm. FT-MZ-1 substantially secreted interleukin 6 (Il-6) coinciding with the inactivation of p53 as a transrepressor on the Il-6 gene promoterKeywords
This publication has 22 references indexed in Scilit:
- p53 gene mutations and protein accumulation in human ovarian cancer.Proceedings of the National Academy of Sciences, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992
- Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell linesInternational Journal of Cancer, 1992
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992
- p53 Mutations in Human CancersScience, 1991
- Primary adenocarcinoma of the Fallopian tubeGynecologic Oncology, 1982
- TUMORS OF THE FALLOPIAN TUBEClinical Obstetrics and Gynecology, 1962